Diabeter Nederland B.V.

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 1 diabetes4 trials

Phase

• Phase 33 trials
• Phase 1/21 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Academisch Ziekenhuis Leiden1 trial
• Diamyd Medical AB1 trial

Running trials

• Recruiting

  A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  NCT07222332· Phase 3· Eli Lilly and Company· Source

• Recruiting

  A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

  NCT07222137· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Tolerogenic dendritic cell therapy in type 1 diabetes; a phase 1b safety and immunological effecitivity study

  2023-508558-25-01· Phase 1/2· Academisch Ziekenhuis Leiden· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 1 diabetes2 recruiting

Closed trials

• Completed

  A clinical study to investigate if the investigational drug Diamyd is safe and can preserve insulin production and secretion in adolescents and adults that have recently been diagnosed type 1 diabetes. The safety of Diamyd will also be investigated. Some subjects may receive a placebo drug.

  NCT05018585· Phase 3· Diamyd Medical AB· Source